WISE:LSEWise PLC Class A Analysis
Data as of 2026-05-23 - not real-time
£924.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Wise Group plc trades around £924, comfortably below its 20‑day (£1,012), 50‑day (£979) and 200‑day (£959) simple moving averages, signaling a technical pull‑back. The RSI of 34 points to oversold conditions, while a bearish MACD histogram reinforces short‑term downside pressure, yet the underlying trend remains bullish. Volatility is elevated at roughly 37% over the past 30 days, but the beta of ~0.06 suggests the stock moves largely independently of broader market swings. Fundamentally, the company posts a solid 9.2% revenue growth, a gross margin near 80%, and an operating margin of 27%, outpacing many peers. The DCF‑derived fair value of about £952 implies a ~26% upside, and the current P/E of 25 is well below the industry average of 40, highlighting relative cheapness. Cash reserves of £1.58 bn dwarf its £0.30 bn debt, delivering a low leverage profile, while free cash flow remains positive. Recent material news – the debut on Nasdaq and a 12% price jump on the US listing – adds a fresh catalyst and broadens the investor base.
Overall, the confluence of a discounted valuation, strong profitability, and a new US market presence creates a compelling entry point, though the high short‑term volatility and bearish technical signals warrant cautious timing. Investors should weigh the upside potential against the near‑term price pressure, with a bias toward buying on dips while monitoring volume trends and any regulatory developments in cross‑border payments.
Overall, the confluence of a discounted valuation, strong profitability, and a new US market presence creates a compelling entry point, though the high short‑term volatility and bearish technical signals warrant cautious timing. Investors should weigh the upside potential against the near‑term price pressure, with a bias toward buying on dips while monitoring volume trends and any regulatory developments in cross‑border payments.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Oversold RSI but bearish MACD
- Recent 12% rally on Nasdaq debut
- Decreasing volume indicating weaker liquidity
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued price vs DCF fair value
- Strong margins and cash generation
- Expanded investor base from US listing
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Sustainable revenue growth and high gross margin
- Robust balance sheet with low leverage
- Strategic positioning in global fintech payments
Key Metrics & Analysis
Financial Health
Revenue Growth9.20%
Profit Margin22.49%
P/E Ratio25.0
ROE29.67%
ROA1.66%
Debt/Equity21.04
P/B Ratio6.6
Op. Cash Flow£5.3B
Free Cash Flow£429.3M
Industry P/E39.5
Technical Analysis
TrendBullish
RSI34.4
Support£900.00
Resistance£1,100.00
MA 20£1,012.86
MA 50£978.89
MA 200£959.29
MACDBearish
VolumeDecreasing
Fear & Greed Index91.61
Valuation
Fair Value£952.45
Target Price£1,167.39
Upside/Downside26.34%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.06
Volatility36.95%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.